1-20 of 21
Pascal Lenain, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Daratumumab after Allogeneic Hematopoietic Stem Cell Transplantation in Multiple Myeloma: Safety and Efficacy. a Retrospective Study from the Cmwp EBMT

Laure Vincent, Luuk Gras, Sr., Patrice Ceballos, MD PhD, Jürgen Finke, Sr., MD PhD, Jakob Passweg, Marie Robin, MD PhD, Laura Rosinol, MD PhD, Monique C. Minnema, Raphael Teipel, MD, JA Van Deosum, Mathias Haenel, MD, Pascal Lenain, MD, Edouard Forcade, MD PhD, Christian Koenecke, MD, Sophie Ducastelle, MD, Jaime Sanz, Wilfried Schroyens, MD PhD, Tsila Zuckerman, MD, Marco Ladetto, MD, Linda Koster, Liesbeth C. de Wreede, PhD, Patrick J Hayden, MD, Stefan Schönland, MD, Ibrahim Yakoub-Agha, Meral Beksac, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 26–27.
https://doi.org/10.1182/blood-2020-138478
Published: 2020
Journal Articles

The Combination of Nilotinib + Pegylated IFN Alpha 2a Provides Somewhat Higher Cumulative Incidence Rates of MR4.5 at M36 Versus Nilotinib Alone in Newly Diagnosed CP CML Patients. Updated Results of the Petals Phase III National Study.

Franck E Nicolini, MD PhD, Gabriel Etienne, MD PhD, Francoise Huguet, MD, Agnès Guerci-Bresler, MD PhD, Aude Charbonnier, MD PhD, Martine Escoffre-Barbe, MD, Viviane Dubruille, MD, Hyacinthe Johnson-Ansah, MD, Laurence Legros, MD PhD, Valerie Coiteux, MD, Pascale Cony-Makhoul, MD, Pascal Lenain, MD, Lydia Roy, MD, Philippe Rousselot, MD PhD, Denis Guyotat, MD PhD, Jean-Christophe Ianotto, MD PhD, Martine Gardembas, MD, Eric Deconinck, MD PhD, Fabrice Larosa, MD, Denis Caillot, MD, Pascal Turlure, MD, Stephane Courby, MD, Philippe Quittet, MD, Eric Hermet, MD, Shanti Ame, MD, Simona Lapusan, MD, Alexandre Deloire, CRA, Stephane Morisset, BioStat, Madeleine Etienne, CRA, Delphine Rea, MD, Stephanie Dulucq, PharmD, PhD, Francois-Xavier Mahon, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 494.
https://doi.org/10.1182/blood-2019-123674
Published: 2019
Journal Articles

Maintenance with Weekly Carfilzomib in Elderly Newly Diagnosed Multiple Myeloma (IFM 2012-03)

Arthur Bobin, Guillemette Fouquet, Alain Duhamel, PU/PH, Salomon Manier, MD PhD, Lionel Karlin, MD, Brigitte Kolb, MD, Mourad Tiab, MD, Carla Araujo, MD, Nathalie Meuleman, PhD MD, Jean Valère Malfuson, MD, Pascal Bourquard, MD, Pascal Lenain, MD, Arnaud Jaccard, MD PhD, Karim Belhadj, MD, Michel Attal, MD PhD, Philippe Moreau, MD, Cyrille Hulin, MD, Xavier Leleu, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3190.
https://doi.org/10.1182/blood-2019-131793
Published: 2019
Journal Articles

Pomalidomide 3rd Line Versus 4 th Line for RRMM

Cécile Gruchet, Stephanie Guidez, Valentine Richez, MD, Cyrille Hulin, Eric G. Voog, MD, Aurore Perrot, Margaret Macro, Olivier Decaux, MD PhD, Gueneau Pauline, Denis Caillot, Anne-Marie Stoppa, MD, Pascal Lenain, MD, Pierre Lebreton, Bruno Royer, MD, Charles Lancesseur, Kamel Laribi, MD, Katell Le Du, MD, Charline Moulin, Catalina Montes De Oca, Arnaud Jaccard, MD PhD, Lotfi Benboubker, MD, Carine Chaleteix, MD, Thomas Systchenko, Niels Moya, Florence Sabirou, Anthony Levy, Arthur Bobin, Paul Franques, Helene Gardeney, Cecile Tomowiak, MD, Deborah Desmier, Antoine Machet, MD, Herve Avet Loiseau, MD PhD, Xavier Leleu, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5633.
https://doi.org/10.1182/blood-2018-99-115449
Published: 2018
Journal Articles

Light Chain Escape in Multiple Myeloma

Thomas Dejoie, MD, Guillemette Fouquet, Cyrille Hulin, Murielle Roussel, Benjamin Hebraud, Lionel Karlin, MD, Brigitte Kolb, MD, Carla Araujo, MD, Nathalie Meuleman, PhD MD, Mourad Tiab, MD, Jean Valère Malfuson, MD, Pascal Bourquard, MD, Pascal Lenain, MD, Arnaud Jaccard, MD PhD, Karim Belhadj, Gérard Lepeu, MD, Marie Lorraine Chretien, MD, Denis Caillot, Jean Fontan, MD, Philippe Rodon, MD, Anna Schmitt, Laurent Voillat, MD, Sophie Cereja, MD, Brigitte Pegourie, MD, Frederique Kuhnowski, MD, Sophie Rigaudeau, MD, Olivier Decaux, MD, Catherine Humbrecht-Kraut, MD, Jamilé Frayfer, MD, Laurent Garderet, Damien Roos-Weil, MD, Jean Claude Eisenmann, MD, Veronique Dorvaux, MD, Eric G. Voog, MD, Claire Mathiot, MD, Jean-Paul Fermand, MD, Thierry Facon, Hervé Avet-Loiseau, MD PhD, Jean Luc Harousseau, MD, Philippe Moreau, Michel Attal, MD PhD, Xavier Leleu, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1881.
https://doi.org/10.1182/blood-2018-99-112396
Published: 2018
Journal Articles

Nilotinib Versus Nilotinib Combined to Pegylated-Interferon Alfa 2a in First-Line Chronic Phase Chronic Myelogenous Leukemia Patients. Interim Analysis of a Phase III Trial

Franck Emmanuel Nicolini, MD PhD, Gabriel Etienne, MD PhD, Francoise Huguet, MD, Agnes Guerci-Bresler, Aude Charbonnier, MD, Martine Escoffre-Barbe, MD, Viviane Dubruille, MD, Hyacinthe Johnson-Ansah, MD, Laurence Legros, MDPhD, Valerie Coiteux, MD, Pascale Cony-Makhoul, MD PhD, Pascal Lenain, MD, Lydia Roy, MD, Philippe Rousselot, Denis Guyotat, Jean-Christophe Ianotto, MD, Martine Gardembas, MD, Fabrice Larosa, MD, Denis Caillot, MD, Pascal Turlure, MD, Stephane Courby, MD, Philippe Quittet, MD, Eric Hermet, MD, Shanti Ame, MD, Simona Lapusan, MD, Verane Schwiertz, PharmD, Stephane Morisset, Stat, Madeleine Etienne, CRA, Delphine Rea, MD PhD, Stephanie Dulucq, PhD, Francois-Xavier Mahon, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 899.
https://doi.org/10.1182/blood.V130.Suppl_1.899.899
Published: 2017
Journal Articles

A Multicenter Open Label Phase II Study of Pomalidomide, Cyclophosphamide and Dexamethasone in Relapse Multiple Myeloma Patients Initially Treated with Lenalidomide, Bortezomib and Dexamethasone

Laurent Garderet, MD PhD, Frederique Kuhnowski, MD, jean Yves Mary, MD, Murielle Roussel, Martine Escoffre-Barbe, MD, Ingrid Lafon, MD, Thierry Facon, MD, Lionel Karlin, MD, Aurore Perrot, MD, Philippe Moreau, MDPhD, Gerald Marit, MD, Anne-Marie Stoppa, MD, Jean-Pierre Marolleau, MD PhD, Carine Chaleteix, MD, Mourad Tiab, Carla Araujo, MD, Pascal Lenain, MD, Margaret Macro, MD, Eric Voog, MD, Lofti Benboubker, MD, Olivier Allangba, MD, Eric Jourdan, MD, Mohamad Mohty, MD PhD, Herve Avet Loiseau, MD PhD, Claire Mathiot, MD, Michel Attal, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 837.
https://doi.org/10.1182/blood.V130.Suppl_1.837.837
Published: 2017
Journal Articles

Combined Genotype Analysis of Tumor and Cell-Free DNA By Ultra-Deep Targeted Sequencing: Correlation with PET-Scan Imaging in a Prospective Cohort of Diffuse Large B-Cell Lymphoma Patients

Elodie Bohers, PhD, Pierre-Julien Viailly, Philippe Bertrand, Stephanie Becker, MD, Philippe Ruminy, PhD, Pascaline Etancelin, PharmD, Catherine Maingonnat, Jean-Michel Picquenot, MD, Anne Lise Menard, MD, Emilie Lemasle, MD, Nathalie Contentin, MD, Stéphane Leprêtre, MD, Pascal Lenain, MD, Aspasia Stamatoullas, MD, Helene Lanic, MD, Julie Libraire, Sandrine Vaudaux, Louis-Ferdinand Pepin, MD, Pierre Vera, Herve Tilly, Fabrice Jardin
Journal: Blood
Blood (2017) 130 (Supplement 1): 309.
https://doi.org/10.1182/blood.V130.Suppl_1.309.309
Published: 2017
Journal Articles

Bortezomib and High-Dose Melphalan Vs. High-Dose Melphalan As Conditioning Regimen before Autologous Stem Cell Transplantation in De Novo Multiple Myeloma Patients: A Phase 3 Study of the Intergroupe Francophone Du Myelome (IFM 2014-02)

Murielle Roussel, Benjamin Hebraud, MD, Valerie Lauwers-Cances, MD, Margaret Macro, MD, Xavier Leleu, MD PhD, Cyrille Hulin, MD, Lionel Karlin, MD, Bruno Royer, MD, Aurore Perrot, MD, Philippe Moreau, MDPhD, Denis Caillot, MD, Sophie Rigaudeau, MD, Mamoun Dib, MD, Emmanuelle Nicolas-Virelizier, MD, Martine Escoffre-Barbe, MD, Karim Belhadj, MD, Brigitte Pegourie, MD, Anne-Marie Stoppa, MD, Carla Araujo, MD, Chantal Doyen, MD, Jean Fontan, MD, Brigitte Kolb, MD, Laurent Garderet, MD PhD, Sabine Brechignac, MD, Jean Valere Malfuson, MD, Veronique Dorvaux, MD, Pascal Lenain, MD, Omar Benbrahim, MD, Arnaud Jaccard, Cecile Borel, MD, Herve Avet Loiseau, MD PhD, Michel Attal, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 398.
https://doi.org/10.1182/blood.V130.Suppl_1.398.398
Published: 2017
Journal Articles

Long-Term Survival of Patients with Chronic Phase Chronic Myeloid Leukemia Who Received Autologous Stem Cell Transplantation and Further Exposed to Tyrosine Kinase Inhibitors. a Study on Behalf of the French Society of Blood and Marrow Transplantation and the French Group of CML

Mauricette Michallet, MD PhD, Mohamad Sobh, Aude Charbonnier, MD, Eric Deconinck, MD PhD, Viviane Dubruille, MD, Valerie Coiteux, MD, Martine Delain, MD, Francoise Huguet, MD, Delphine Rea, MD, Dominique Bron, Nicole Raus, Data Manager, Alain Jacques Delmer, MD, Pascal Lenain, MD, Noel Milpied, Francois-Xavier Mahon, MD PhD, Franck Emmanuel Nicolini, MD PhD, Gabriel Etienne, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4540.
https://doi.org/10.1182/blood.V130.Suppl_1.4540.4540
Published: 2017
Journal Articles

Carfilzomib Weekly Plus Melphalan and Prednisone in Newly Diagnosed Elderly Multiple Myeloma (IFM 2012-03)

Xavier Leleu, MD PhD, Lionel Karlin, Brigitte Kolb, Mourad Tiab, MD, Carla Araujo, Nathalie Meuleman, Thierry De Revel, Pascal Bourquard, Pascal Lenain, MD, Murielle Roussel, MD, Arnaud Jaccard, MD PhD, Marie-Odile Petillon, Karim Belhadj-Merzoug, Gerard Lepeu, Marie-Lorraine Chretien, Jean Fontan, Philippe Rodon, MD, Anna Schmitt, Fritz Offner, Laurent Voillat, Sophie Cereja, Frederique Kuhnowski, Sophie Rigaudeau, Olivier Decaux, MD PhD, Catherine Humbrecht-Kraut, Jamile Frayfer, Olivier Fitoussi, Damien Roos Weil, Jean Claude Eisenmann, MD, Veronique Dorvaux, Eric G. Voog, MD, Cyrille Hulin, Michel Attal, Philippe Moreau, Thierry Facon, MD
Journal: Blood
Blood (2015) 126 (23): 3028.
https://doi.org/10.1182/blood.V126.23.3028.3028
Published: 2015
Journal Articles

Ponatinib for Chronic Phase (CP) CML Failing Two or More Tyrosine Kinase Inhibitors (TKI) or Harboring a T315I Mutation in the Real Life: Pearl Observational Study

Franck E. Nicolini, MD PhD, Mael Heiblig, MD, Stéphane Morisset, Stat, Denis Caillot, Valérie Coiteux, MD, Aude Charbonnier, MD, Françoise Huguet, MD, Viviane Dubruille, MD, Gabriel Etienne, MD PhD, Pascal Lenain, MD, Francois Guilhot, MD, Laurence Legros, MD, Philippe Rousselot, MD PhD, Shanti Amé, MD, Rémy DeFrance, MD, Jeremy Ruby, CRA, Francois-Xavier Mahon, MD PhD Professor, Delphine Rea
Journal: Blood
Blood (2015) 126 (23): 4039.
https://doi.org/10.1182/blood.V126.23.4039.4039
Published: 2015
Journal Articles

Pegylated Interferon-Alpha 2a in Combination with Nilotinib As First-Line Therapy in Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (Nilopeg trial). Four-Year Follow-up Results

Franck E. Nicolini, MD PhD, Gabriel Etienne, MD PhD, Viviane Dubruille, MD, Lydia Roy, MD, Françoise Huguet, MD, Laurence Legros, MD, Stéphane Giraudier, MD PhD, Valérie Coiteux, MD, Agnes Guerci-Bresler, MD, Pascal Lenain, MD, Delphine Rea, Shanti Amé, MD, Pascale Cony-Makhoul, MD, Martine Gardembas, MD, Eric Hermet, MD, Philippe Rousselot, MD PhD, Marie-Claude Gagnieu, PharmD, PhD, Stéphane Morisset, Stat, Christine Pivot, PharmD, Madeleine Etienne, CRA, Francois Guilhot, MD, Stéphanie Dulucq, PharmD, PhD, Francois-Xavier Mahon, MD PhD Professor
Journal: Blood
Blood (2015) 126 (23): 1578.
https://doi.org/10.1182/blood.V126.23.1578.1578
Published: 2015
Journal Articles

Combination of Dasatinib and Peg-Interferon Alpha 2b in Chronic Phase Chronic Myeloid Leukemia (CP-CML) First Line: Preliminary Results of a Phase II Trial, from the French Intergroup of CML (Fi-LMC)

Lydia ROY, MD, Jean-Claude Chomel, PharmD PhD, Joelle Guilhot, PhD, Agnes Guerci-Bresler, MD, Martine Escoffre-Barbe, Stéphane Giraudier, MD PhD, Aude Charbonnier, Viviane Dubruille, MD, Françoise Huguet, Hyacinthe Johnson-Ansah, MD, Pascal Lenain, MD, Shanti Amé, MD, Gabriel Etienne, MD PhD, Franck E. Nicolini, Delphine Rea, MD PhD, Pascale Cony-Makhoul, MD, Stephane Courby, MD, Jean-Christophe Ianotto, MD, Laurence Legros, MD, Martine Delain, MD, Valérie Coiteux, MD, Eric Hermet, MD, Martine Gardembas, MD, Mathieu Molimard, MD PhD, Jean-Michel Cayuela, Marie Thibaud, CRA, Sophie Duranton, PharmD, Francois-Xavier Mahon, MD PhD, Philippe Rousselot, MD PhD Professor, Francois Guilhot, MD
Journal: Blood
Blood (2015) 126 (23): 134.
https://doi.org/10.1182/blood.V126.23.134.134
Published: 2015
Journal Articles

Bortezomib, Thalidomide and Dexamethasone (VTD) Is Superior to Bortezomib, Cyclophosphamide and Dexamethasone (VCD) Prior to Autologous Stem Cell Transplantation for Patients with De Novo Multiple Myeloma. Results of the Prospective IFM 2013-04 Trial

Philippe Moreau, Cyrille Hulin, Margaret MACRO, MD, Denis Caillot, Carine Chaleteix, Murielle Roussel, Laurent Garderet, MD, Bruno Royer, MD, Sabine Brechignac, MD, Mourad Tiab, MD, Mathieu Puyade, MD, Martine Escoffre, Anne-Marie Stoppa, MD, Thierry Facon, Brigitte Pégourie, Driss Chaoui, MD, Arnaud Jaccard, MD PhD, Borhane Slama, Gerald Marit, Kamel Laribi, Pascal Godmer, MD, Odile Luycx, Jean Claude Eisenmann, MD, Olivier Allangha, Sylvie Glaisner, Mamoun Dib, Carla Araujo, Jean Fontan, Karim Belhadj, MD, Marc Wetterwald, MD PhD, Veronique Dorvaux, Jean-Paul Fermand, Philippe Rodon, MD, Brigitte Kolb, Pascal Lenain, MD, Lucie Planche, Laetitia Biron, Helene Caillon, Herve Avet-Loiseau, Thomas Dejoie, Michel Attal
Journal: Blood
Blood (2015) 126 (23): 393.
https://doi.org/10.1182/blood.V126.23.393.393
Published: 2015
Journal Articles

Bendamustine, Bortezomib and Dexamethasone (BVD) In Elderly Patients With Multiple Myeloma In First Relapse: Final Analysis Of The Intergroupe Francophone Du Myelome (IFM) 2009-01 Trial

Philippe Rodon, MD, Cyrille Hulin, MD, Brigitte Pegourie, MD, Mourad Tiab, MD, Bruno Anglaret, MD, Lotfi Benboubker, MD, Henry Jardel, Olivier Decaux, MD, Brigitte Kolb, MD, Murielle Roussel, MD, Laurent Garderet, MD, Xavier Leleu, MD, PhD, Olivier Fitoussi, MD, Carine Chaleteix, MD, Philippe Casassus, MD, Pascal Lenain, MD, Bruno Royer, MD, Anne Banos, MD, Riad Benramdane, Pascale Cony-Makhoul, MD, Mamoun Dib, Jean Fontan, Anne-Marie Stoppa, MD, Catherine Traulle, MD, Jean-Pierre Vilque, MD, Marie-Odile Petillon, Claire Mathiot, MD, Hervé Avet-Loiseau, MD, PhD, Philippe Moreau, MD
Journal: Blood
Blood (2013) 122 (21): 1971.
https://doi.org/10.1182/blood.V122.21.1971.1971
Published: 2013
Journal Articles

Clinical Relevance Of Cachexia Assessed By An Anthropometric Tool In Elderly Patients With Diffuse Large B-Cell Lymphoma Treated By Immunochemotherapy

Helene Lanic, MD, Jerome Kraut, MD, Romain Modzelewski, Florian Clatot, MD, Jean-Michel Picquenot, MD, Nathalie Contentin, MD, Pascal Lenain, MD, Luminata Groza, MD, Emilie Lemasle, MD, Carole Fronville, MD, Nathalie Cardinael, MD, Marie-Laure Fontoura, MD, Chamseddine Ali, MD, Oana Brehar, MD, Aspasia Stamatoullas, MD, Stéphane Lepretre, MD, Herve Tilly, MD, Fabrice Jardin, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2926.
https://doi.org/10.1182/blood.V122.21.2926.2926
Published: 2013
Journal Articles

Ruxolitinib Therapy in Myelofibrosis: Analysis of 241 Patients Treated in Compassionate Use (French “ATU” program) by the French Intergroup of Myeloproliferative Neoplasms (FIM).

Annalisa Andreoli, MD, Jerome Rey, MD, Charles Dauriac, MD, Raoul Herbrecht, MD, Franck E. Nicolini, MD, PhD, Christian Recher, MD, PhD, Philippe Rousselot, MD, PhD, Jacques Delaunay, MD, Bernard Drenou, MD, PhD, Dana Ranta, MD, Laurence Legros, MD, PhD, Martine Delain, MD, Pascale Cony-Makhoul, MD, Jean-François Viallard, MD, PhD, Sorin Visanica, MD, Sophie Lefort, MD, Brigitte Dupriez, MD, Valérie Coiteux, MD, Denis Guyotat, MD, Borhane Slama, MD, Khaled Benabed, MD, Jean-Loup Demory, MD, Stephane Giraudier, MD, PhD, Damien Roos-Weil, MD, Laurence Sanhes, MD, Anne Quinquenel, MD, Pascal Lenain, MD, Valérie Ugo, MD, PhD, Jean-Jacques Kiladjian, MD, PhD, Lydia Roy, MD
Journal: Blood
Blood (2012) 120 (21): 2841.
https://doi.org/10.1182/blood.V120.21.2841.2841
Published: 2012
Journal Articles

Pegylated Interferon-α 2a in Combination to Nilotinib As First Line Therapy in Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia Provides High Rates of MR 4.5 . Preliminary Results of a Phase II Study.

Franck E. Nicolini, MD, PhD, Gabriel Etienne, MD, PhD, Viviane Dubruille, MD, Lydia Roy, MD, Françoise Huguet, Laurence Legros, MD, PhD, Stephane Giraudier, MD, PhD, Valérie Coiteux, MD, Agnès Guerci-Bresler, MD, Pascal Lenain, MD, Delphine Rea, MD, PhD, Shanti Ame, MD, Pascale Cony-Makhoul, MD, Martine Gardembas, MD, Eric Hermet, MD, Philippe Rousselot, MD, PhD, Marie-Claude Gagnieu, PharmD, PhD, Stephane Morisset, Stat., Christine Pivot, Pharm., Madeleine Etienne, CRA, François Guilhot, MD, Stephanie Dulucq, MD, Francois-Xavier Mahon, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 166.
https://doi.org/10.1182/blood.V120.21.166.166
Published: 2012
Journal Articles

Bendamustine, Bortezomib and Dexamethasone (BVD) in Elderly Patients with Multiple Myeloma in First Relapse: Updated Results of the Intergroupe Francophone Du Myelome (IFM) 2009-01 Trial

Philippe Rodon, MD, Cyrille Hulin, MD, Brigitte Pegourie, MD, Mourad Tiab, MD, Bruno Anglaret, MD, Lotfi Benboubker, MD, PhD, Henry Jardel, MD, Olivier Decaux, MD, PhD, Brigitte Kolb, MD, Murielle Roussel, MD, Laurent Garderet, MD, Xavier Leleu, MD, PhD, Olivier Fitoussi, MD, Carine Chaleteix, MD, Philippe Casassus, MD, Pascal Lenain, MD, Philippe Moreau, MD, Marie Odile Petillon, MD, Claire Mathiot, MD, Herve Avet-Loiseau, MD
Journal: Blood
Blood (2012) 120 (21): 4044.
https://doi.org/10.1182/blood.V120.21.4044.4044
Published: 2012